Press release
Ischemic Heart Disease Drugs Market Size | COVID-19 Impact Analysis | Forecast to 2025
Request a Free Sample of our Ischemic Heart Disease Drugs Market: https://www.omrglobal.com/request-sample/ischemic-heart-disease-market
Various pivotal factors that are augmenting the ischemic heart disease market includes growing incidence and prevalence rate of hypertension, high cholesterol, diabetes, and obesity across the globe. Government funding for diagnosis, treatment and research and their initiative programs to increase the awareness toward disease is another major factor augmenting the growth of the market. However, the high costs of treatment coupled with the regular uncertainty seen in reimbursement policies can hamper the growth of the market. Opportunities that are expected to augment the market includes increasing awareness among people towards the heart diseases and improving healthcare system and healthcare spending in emerging economies.
A full Report of Ischemic Heart Disease Drugs Market is Available at: https://www.omrglobal.com/industry-reports/ischemic-heart-disease-market
A number of pipeline products by the major market player and various devices & drugs are expected to get Food and Drug Administration (FDA) approval which is also contributing in the growth of the market. For instance, in March 2017, FDA approved COBRA PzF NCS (NanoCoated coronary stent) system in order to improve coronary luminal diameter in certain patients with ischemic heart disease. In May 2018, the US FDA approved the use of replacement heart valve in paediatric patients during the treatment of heart diseases.
Global ischemic heart disease market is further analyzed on the basis of the geographical regions which are contributing significantly in the market. On the basis of geography, the market is divided into North America, Europe, Asia-Pacific, and Rest of the World. North America and Europe are expected to have a major market for ischemic heart disease during the forecast period. As per the Centers for Disease Control and Prevention (CDC), around 800,000 mortalities are reported due to ischemic disease every year in the US. As per the European Heart Network, around 3.9 million mortalities are reported due to CVDs (cardiovascular diseases) every year in Europe, wherein, nearly 1.8 million cases are reported in European Union. Asia-Pacific is projected to exhibit the fastest growth in the global ischemic heart diseases market during the forecast period. This is mainly owing to the rising prevalence of heart diseases and strokes and increasing awareness towards CAD.
Ischemic Heart Disease Drugs MARKETSEGMENTATION
ByDiseaseType
• Angina
MyocardialInfarction
IschemicStroke
ByDiagnosisMethod
•
Electrocardiogram (ECG)
Echocardiogram
ChestX-Ray
CardiacCatheterization
CoronaryAngiogram
ByTreatment
•
Medication
NSAID
Statins
Blocker
CalciumChannelBlocker
ACEInhibitors
Others (OrganicNitrates)
Surgery
CoronaryStent
Angioplasty
COMPETITIVELANDSCAPE
•
KeyStrategyAnalysis
KeyCompanyAnalysis
REGIONALANALYSIS
•
NorthAmerica
UnitedStates
Canada
Europe
UK
Germany
Italy
Spain
France
RoE
Asia-Pacific
India
China
Japan
RestofAsia-Pacific
RestoftheWorld (RoW)
COMPANYPROFILES
•
AbbottLaboratories
AmgenInc.
AstraZenecaPLC
BayerAG
BostonScientificCorp.
CardinalHealth, Inc.
DaiichiSankyoCo. Ltd.
EdwardsLifesciencesCorp.
GeneralElectricCo.
Genentech, Inc.
KoninklijkePhilipsN.V.
LepuMedicalTechnology (Beijing) Co., Ltd.
Medtronic, PLC
MerckKGaALtd.
SanofiSA
SiemensHealthcarePvt. Ltd.
StrykerCorp.
TERUMOCORP.
W. L. Gore & Associates, Inc.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/ischemic-heart-disease-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ischemic Heart Disease Drugs Market Size | COVID-19 Impact Analysis | Forecast to 2025 here
News-ID: 2219509 • Views: …
More Releases from Orion Market Research
Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sust …
Hair accessories market was valued at $23.8 billion in 2024 and is projected to reach $55.2 billion in 2035, growing at a CAGR of 8.2% during the forecast period (2025-2035). Generation Z, with significant disposable income, is transforming the hair accessories category in a major way. Their close connection to trends creates a unique feeling of urgency to self-express through fashion, such as clips, scrunchies, and barrettes. It has become…
Railway Management System Market Size Analysis, Competitive Insights, Leading Pl …
Railway System (or Railway Management System) market was valued at approximately USD 28.28 billion, and it is expected to reach about USD 45.19 billion by 2033, growing at a CAGR of around 4.8% from 2024 to 2033.
Railway Management System Market Overview
The Railway Management System market includes technologies and systems used to plan, monitor, and manage railway operations-everything from traffic and signaling systems to asset and maintenance management, passenger information,…
Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Player …
Monocalcium Phosphate market was valued at about USD 4.2 billion, and it is anticipated to reach around USD 6.9 billion by 2033, growing at a CAGR of approximately 5% from 2023 to 2033.
Monocalcium Phosphate Market Overview
Monocalcium phosphate (MCP) is a calcium-phosphorus compound widely used in animal feed, fertilizers, and also in food and beverage applications (for example as leavening agent or acidity regulator), due to its solubility and bioavailability. The…
Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Player …
Automotive Lubricants Market was valued at approximately USD 70.44 billion. By 2033, it is expected to reach around USD 107.09 billion, growing at a CAGR of about 3.3% from 2025 to 2033.
Automotive Lubricants Market Overview
The automotive lubricants market consists of products like engine oils, gear oils, greases, hydraulic fluids, and transmission fluids that reduce friction, wear and tear, and improve efficiency and lifespan of vehicle components. Demand is driven by…
More Releases for Ischemic
Rising Hypertension Fuels Growth In Acute Ischemic Stroke Therapeutics Market: A …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Acute Ischemic Stroke Therapeutics Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for acute ischemic stroke therapeutics has seen appreciable growth lately. Its expansion is expected to proceed from $9.24 billion in 2024 to about $10.12 billion in 2025, manifesting a compound…
Rising Hypertension Fuels Growth In Acute Ischemic Stroke Therapeutics Market: K …
The Acute Ischemic Stroke Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Acute Ischemic Stroke Therapeutics Market Size During the Forecast Period?
The acute ischemic stroke therapeutics market has experienced significant growth in recent years. It is projected to rise from…
Ischemic Stroke Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Ischemic Stroke Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in Ischemic Stroke pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Ischemic Stroke Pipeline Report
• Over 50+ Ischemic Stroke…
Ischemic Cardiomyopathy Treatment Market Growth, Challenges, Opportunities and E …
"The new report has been added by qyresearch.com to provide detailed insight into the global Ischemic Cardiomyopathy Treatment market. The study will help to get a better understanding about the Ischemic Cardiomyopathy Treatment industry competitors, a channel for the distribution, Ischemic Cardiomyopathy Treatment growth potential, potentially disruptive trends, Ischemic Cardiomyopathy Treatment industry product innovations, market size value/volume (regional/country level, Ischemic Cardiomyopathy Treatment industry segments), market share of top players/products.
Due to…
Transient Ischemic Attack Market Forecast by 2025
Recent Transient Ischemic Attack market research and the current scenario as well as future market potential of "Global Transient Ischemic Attack Market Professional Survey Report 2020". The Transient Ischemic Attack Market comprehensively describes the market and prognosticates it to describe a highly illustrious growth during the anticipated years. The report offers an in-depth analysis of current and future Transient Ischemic Attack Market outlook across the globe. The report is projected…
Acute Ischemic Stroke Diagnosis And Treatment Market : Increased Usage of Advanc …
A recent report on global acute ischemic stroke diagnosis and treatment market has been analyzed by Transparency Market Research (TMR). The market for acute ischemic stroke diagnosis and treatment is expected to increase during the forecast period with the increasing incidence of strokes, technically advanced techniques, and successful results through treatment surgeries. Technological advancement and constant efforts made by leading companies are providing improved treatments for people suffering from ischemic…
